Program at a glance

The ANZCHOG ASM 2022 program will include plenary sessions, invited speaker sessions, industry involvement and concurrent paper sessions.

As more details of the program and speakers are confirmed, this page will be updated. Refer back to this page regularly for updates. Please note that the program is subject to change.

Sign up to our mailing list today to be kept up to date on program release dates.

The pre-ASM nursing workshop is included with the Full ASM Delegate registration type. Space for this workshop is limited and you will need to indicate during the registration process if you would like to attend.

Venue: Castlereagh Room 2, Sheraton Grand Hyde Park, Sydney

0900-1630

ANZCHOG Nurses Pre Conference Workshop Program

0900-0905
Welcome & housekeeping
0905-0950

The importance of self-care and the impact of the pandemic

Dr Justin Baker

St Jude Children’s Research Hospital

0950-1035
Hiding in plain sight. Nursing’s superpower

Prof Mei Krishnasamy
Peter MacCallum Cancer Centre
1035-1055
Morning tea
1055-1120
Genomics for everyone

Dr Kim Alexander
Queensland University of Technology
1120-1145
Haemophilia overview and what’s the treatment plan for 2022

Grainne Dunne
Sydney Children’s Hospital
1145-1210
Fertility and emerging therapies

Tejnei Vaishnav
Royal Hospital for Women, NSW
1210-1230
The role and value of the research nurse

A/Prof Natalie Bradford
Queensland University of Technology
1230-1300
Lunch
1300-1430
What’s on your eLearning wishlist? eviQ Education showcase and workshop
1430-1450
Abstract submissions - TBC
1450-1505
Afternoon tea
1505-1535
Navigating end-of-life conversations with adolescents and young adults using the Australian Voicing My Choices tool: best practice & case examples

Dr Ursula Samson Daly, Cath O’Dwyer & Fiona Maguire
Sydney Children’s Hospital
1535-1605
Children and Adolescents with Cancer: Neuropsychological effects, education needs and interventions
Dr Soheil Afshar
Sydney Children’s Hospital

1605-1635

Health and wellbeing after cancer: a multidisciplinary program for long-term survivors of childhood malignancies

Dr Christina Signorelli, Karen Johnston & Rachael Bell
Sydney Children’s Hospital
1635-1645
Evaluations & close
1645-1730
Nurses Annual General Meeting

Brought to you by

You will have the option to register your attendance to the Parent Program during the registration process for the ASM.

If you would like to attend the virtual Parent Program only please proceed via the standard registration portal and use registration code*: PAR22 when prompted in order to bypass the ASM registration.

*Please note, by using this code, you will not be registered to attend the ASM or any of the social functions.

Example

0930-1510
Parent Program
Chair: Donna Drew
0930-0935
Welcome and house keeping for virtual attendees
0935-0955
Keeping up with school during and after childhood cancer

Joanna Fardell

0955-1015

Managing social challenges during and after childhood cancer

Clarissa Schilstra
1015-1030
Questions
1030-1045
Morning tea
1045-1115

When your child has cancer, goals of care, hope and compassion

Justin Baker

1115-1145
Minimising the psychological impact of cancer treatment on children and adolescents

Liane Willis
1145-1215
Questions
1215-1300
Lunch
Chair: Joanna Fardell
1300-1320
Staying fit and active during and after cancer

Lauren Ha
1320-1340
Managing the needs of siblings who have a brother or sister with cancer

Brittany McGill
1350-1400
Afternoon tea
1400-1420
When and how do I talk to my child about their cancer experience : side effects, experience, fertility

Tali Foreman
1420-1440
Survivor’s Story: Clarissa will share her story about her cancer diagnosis, relapse, survivorship, academic achievements and being a mum

Clarissa
1500-1510
Summary of the day & close

Information to come

0900-0915
Opening ceremony
0915-1015
Plenary 1

Dr Justin Baker
St Jude Children’s Research Hospital

1015-1045
Morning tea - Trade display and poster viewing
1045-1130
Plenary 2
Old drugs and new: Still so much to learn about haemostasis in children
Prof Paul Monagle
Kids Cancer Centre, Sydney Children's Hospital/University of Melbourne
1130-1215
Plenary 3
Fertility preservation in young people: The new standard of care
A/Prof Antoinette Anazodo
Kids Cancer Centre, Sydney Children's Hospital
1215-1315
Lunch - Trade display and poster viewing
1245-1315
Partner lunch symposium 1

Prof Selim Corbacioglu
Children's Hospital Regensburg Germany

Brought to you by

1315-1445
Concurrent 1: Non malignant haematology
Concurrent 2: Solid tumours
Concurrent 3: Patient experience

Chair: Prof Paul Monagle

Current management of sickle cell disease
Dr Anthea Greenway
Royal Children's Hospital Melbourne

Iron deficiency anaemia
Prof Sant-Rayn Parischa
Walter and Eliza Hall Institute of Medical Research

Transfusion medicine
Dr Gemma Crighton

Royal Children's Hospital Melbourne

Chair:

Current therapies in neuroblastoma
Dr Toby Trahair
Kids Cancer Centre, Sydney Children's Hospital

 

Oral abstracts

Chair:

Hoping against hope - Supporting hope in advancing illness
Dr Justin Baker
St Jude Children's Hospital Memphis

ASSET: Collecting patient toxicity data and quality of life data together, where to next?
Dr Joanna Fardell
Kids Cancer Centre, Sydney Children's Hospital

Do long term survivors adhere to recommendations provided by MDT review?
Dr Jordana McLoone
Kids Cancer Centre, Sydney Children's Hospital

Developing a model of care for AYA patients with culturally diverse backgrounds
Dr Azhani Amiruddin
Children's Hospital Westmead

1445-1515
Afternoon tea - Trade display and poster viewing
1445-1700
Concurrent 4: Non malignant haematology
Concurrent 5: Solid tumours
Concurrent 6: Patient experience

Chair: Prof Paul Monagle

Novel treatments of ITP
Dr Sally Campbell
Royal Brisbane &Women's Hospital

Current care in haemophilia
Janine Furmedge
Royal Children's Hospital Melbourne

National guidelines for ITP
Dr Tina Carter & Dr Vanessa Verissimo
Perth Children's Hospital 

 

Chair:

Paediatric and adolescent thyroid cancer
A/Prof Antoinette Anazodo
Kids Cancer Centre, Sydney Children's Hospital

Oral abstracts

Chair:

Health workers' understanding of and barriers to palliative care services for Aboriginal children with cancer
Dr Sophie Jessop
Kids Cancer Centre SCH

 

Oral abstracts

1700-1900
Welcome reception
0730-0830
Partner breakfast 1
Partner breakfast 2
Partner breakfast 3
0900-1000
Plenary 4
Dr Robert Battisti
Children's Hospital Westmead
1000-1030
Morning tea - Trade display and poster viewing
1030-1130
ANZCHOG 2022 Best abstracts
1130-1200
Lifetime achievement award

A history of paediatric stem cell transplantation in Australia

Prof Marcus Vowels

1200-1330
Lunch - Trade display and poster viewing
1230-1300
Partner lunch symposium 2

Brought to you by

1300-1430
Concurrent 7: Neuro-oncology
Concurrent 8: Cellular therapy
Concurrent 9: Global oncology in Oceania: A joint SIOP-ANZCHOG symposium across disciplines

Chair:

A/Prof Jordan Hansford
Women's and Children's Hospital Adelaide

 

Oral abstracts

Chair:

Professor Claire Wakefield
President, SIOP Oceania

Dr Michael Sullivan
Royal Children's Hospital Melbourne

1430-1500
Afternoon tea - Trade display and poster viewing
1500-1630
Concurrent 10: Neuro-oncology
Concurrent 11: Leukaemia
Concurrent 12: ANZCHOG ACCT Trial update
Chair: Dr Maria Kirby
ANZCHOG Medical Director
1630-1700
Meet the experts 1: Clinical use of asparaginase
Meet the expert 2
Meet the expert 3
Dr Siobhan Cross
Christchurch NZ

Bridget Smith
Monash Children's Hospital

Brought to you by

Brought to you by

1900-2300
Gala dinner
0900-1100
Debate: When is enough enough? The role of phase 1 trials
Moderator: Annabel Crabb
ABC journalist
1100-1130
Morning tea - Trade display and poster viewing
1130-1230
Plenary 5
Dr Justin Baker
St Jude Children's Hospital Memphis
1230-1300
Closing ceremony
Day 1 - Thursday 28 July
1245 - 1315
Partner Lunch Symposium

Prof Selim Corbacioglu
Children's Hospital Regensburg Germany

Brought to you by

Day 2 - Friday 29 July
0730 - 0830
Partner breakfast 1
Partner breakfast 2
1230 - 1300
Partner Lunch Symposium 2
1630 - 1700
Meet the experts 1
Clinical use of asparaginase
Meet the experts 2

Dr Siobhan Cross
Christchurch NZ

Bridget Smith
Monash Children's Hospital

Brought to you by

Brought to you by

Jazz Pharmaceuticals is a global Biopharmaceutical Company whose purpose is to transform the lives of patients and their families through innovation. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options so they can live their lives more fully.

We have a diverse portfolio of marketed medicines and novel product candidates, from early- to latestage development, in Neuroscience and Haematology/Oncology. Within these therapeutic areas, we are identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science.

Jazz Pharmaceuticals has employees around the globe including Australia and New Zealand, serving patients in nearly 75 countries

Medical Information
Phone: 1800577422
Email: medinfo-apac@jazzpharma.com

Adverse event
Phone: 1800577422
Email: AEReporting@jazzpharma.com


To report a Product Complaint, please email:
productcomplaints@jazzpharma.com

Dr Robert Battisti

Children’s Hospital Westmead

Dr Battisti is a Clinical Psychologist and Researcher at the Cancer Centre for Children at the Children’s Hospital at Westmead, and an Honorary Research Associate at the University of Sydney. Dr Battisti completed his PhD at the University of Wollongong and a postdoctoral position with the National Drug and Alcohol Research Centre (NDARC) at the University of New South Wales in partnership with the Brain and Mind Centre at the University of Sydney. Dr Battisti is also on the Board of Directors for the Australian Clinical Psychology Association (ACPA). His clinical background is in child, adolescent and young adult (AYA) psychology as well as parenting psychology, with expertise in paediatric cancer including childhood cancer survivorship.

A/Prof Antoinette Anazodo

Kids Cancer Centre, Sydney Children’s Hospital

A/Professor Anazodo is the lead clinician for Youth Cancer Services in NSW and the ACT, and the Director of the Adolescent and Young Adult Cancer Service encompassing Sydney Children’s Hospital and Prince of Wales Hospital. She leads the Future Fertility research program and has been instrumental in making fertility preservation accessible for oncology patients all around Australia, by developing Medicare item numbers for public funding. A/Professor Anazodo chairs the Australian AYA fertility preservation group, which leads the development of guidelines in the field of oncofertility. She has over 100 publications in the fields of adolescent medicine and oncofertility, and is a principle investigator on multiple successful grants from both the NHMRC and Cancer Australia. A/Professor Anazodo has received a number of awards for her work including a NSW Premiers award in 2018 and a Medal of the Order of Australia in 2021.

Dr Justin Baker

St Jude Children’s Research Hospital

Dr Baker is the Division Chief of Quality of Life and Palliative Care at St. Jude Children’s Research Hospital, Memphis, TN, USA. He is trained in paediatric haematology/oncology, as well as Hospice and Palliative Medicine. Dr Baker is a world leader in paediatric palliative care and quality of life, with over 100 publications in the field. His research focuses on integrating palliative care into the ongoing care of children with cancer, the ethical consideration of early phase trials, and paediatric palliative care in developing countries. He was awarded the AAHPM Inspirational Leader in Hospice and Palliative Medicine in 2014, and the St. Jude Communicator of the Year in 2017. Dr Baker has led the development of guidelines in paediatric palliative care and quality of life that have been implemented in centres throughout the world, and has been an invited speaker at paediatric oncology and palliative care conferences across the globe.

Dr Robert Battisti

Children’s Hospital Westmead

Dr Battisti is a Clinical Psychologist and Researcher at the Cancer Centre for Children at the Children’s Hospital at Westmead, and an Honorary Research Associate at the University of Sydney. Dr Battisti completed his PhD at the University of Wollongong and a postdoctoral position with the National Drug and Alcohol Research Centre (NDARC) at the University of New South Wales in partnership with the Brain and Mind Centre at the University of Sydney. Dr Battisti is also on the Board of Directors for the Australian Clinical Psychology Association (ACPA). His clinical background is in child, adolescent and young adult (AYA) psychology as well as parenting psychology, with expertise in paediatric cancer including childhood cancer survivorship.

Prof Paul Monagle

University of Melbourne

Professor Monagle is an internationally renowned paediatric haematologist and haemato-pathologist. He is a Professor of Paediatrics at the University of Melbourne, a clinical Haematologist at the Kids Cancer Centre, Sydney Children’s Hospital, and an Honorary Fellow and Group Leader in Haematology Research at the Murdoch Children’s Research Institute. Professor Monagle is a world expert on thrombosis and coagulation, with over 300 publications in the field of paediatric haematology. His research group holds multiple NHMRC grants and is currently leading work into COVID-19 associated thrombosis. Professor Monagle was awarded the Outstanding Research Award in Paediatric Cardiology by the American Heart Association in 2008, and delivered the Barry Firkin Oration for the Thrombosis & Haemostasis Society of Australia and New Zealand in 2018. He has played a key role in designing multiple international multi-centre trials, and been an invited speaker at haematology conferences across the globe.

Prof Marcus Vowels

Professor Vowels is a renowned early leader of the paediatric oncology and haematology disciplines in Australia. Professor Vowels established the first bone marrow transplant program in Australia at the then Prince of Wales Children’s Hospital, now Sydney Children’s Hospital in Randwick, NSW. Professor Vowels established the Australian Cord Blood Bank and was a founding trustee of the Australian Cord Blood Foundation. Professor Vowels has over 100 peer reviewed publications, he was the founding member of a number of editorial boards of discipline specific journals and is the author of multiple book chapters. Professor Vowels was the President of the Australian and New Zealand Children’s Cancer Study Group from 1990 to 1994, and was awarded a Member of the Order of Australia (AM) for his service to medicine, particularly in the fields of childhood leukaemia and cancer.

Annabel Crabb

ABC Journalist

Annabel Crabb is one of Australia’s most beloved journalists. She is an ABC writer and presenter who has covered Australian politics for 20 years but also is nationally well-known for her insightful and humorous analysis on gender and current affairs. 

Annabel recently created and presented the ground breaking Ms Represented, unearthing stories from the 100 years of women in Australian parliaments. For the ABC, she has also devised and presented six seasons of the enormously popular Kitchen Cabinet, and “The House with Annabel Crabb – the fly-on-the-wall documentary on Australian Parliament.” She also presents the ABC’s hit culinary history series Back In Time For Dinner, and co-stars in Tomorrow Tonight with Charlie Pickering.

With friend and ABC colleague Leigh Sales, Australia’s pre-eminent current affairs journalist, Annabel hosts the top-rating podcast Chat 10 Looks 3. Their first book together, Well Hello, was published in September 2021.

Annabel is an avid baker and proud mother of three.

Bayer is a global enterprise with core competencies in healthcare and agriculture. Through science and innovation, the company is committed to the lives of people impacted by cancer. Bayer’s oncology research prioritises cutting-edge science across a range of therapeutic platforms to give patients and clinicians a multitude of options in the fight against cancer.

For more than 20 years, Illumina has aspired to improve human health by unlocking the power of the genome. As we move towards precision medicinein pediatric cancer, we have only just begun to discover the true impact of genomics. Learn how Illumina technologies is enabling novel insights into childhood cancer risk and treatment. Visit: https://sapac.illumina.com/destination/Precision-Medicine-in-Pediatric-Cancers.html

We are a dynamic, global biopharmaceutical company focused on oncology and rare disease, continuously striving to confront gaps in patient care. EUSA Pharma is committed to deliver solutions that can have a meaningful effect on life, helping patients across a range of therapy areas. We are continuously looking for new opportunities to confront current gaps in patient care. Our ambition and entrepreneurial culture drive us to explore, acquire and in-license products that we believe can bring about real change for patients.

Servier is a privately owned pharmaceutical company, governed by a non-profit foundation that is committed to therapeutic progress to serve patient needs. Servier has a long-standing commitment to research and development.

Worldwide approximately 25% of branded product turnover is reinvested into research and development through the Servier Foundation, with half of that investment dedicated to research to help fight cancer.

Servier has significant investment in new products in early development in the areas of Oncology and Haematology with broad research and development platforms in cancer cell apoptosis and immuno-oncology. Servier Australia is also home to the Asia-Pacific clinical trial hub.

Servier is proud to support innovative partnering programs with world class institutions including WEHI in Australia to further advance scientific understanding in the area of oncology

Information coming soon.

The Robert Connor Dawes (RCD) Foundation was created in June 2013 in the memory of Robert ‘Connor Dawes’ who lost his 16-month battle with an ependymoma brain tumour at just 18 years of age. The RCD Foundation works to support brain matters projects in the areas of research, care and development – to fund the science to fight paediatric brain cancer and support patients in the meantime.

The Foundation operates in Australia and the US, and to date has invested $3.45M into paediatric brain cancer research, funding basic science and translational projects, as well as capacity building grants through fellowships, scholarships and travel grants. It has also leveraged another $10M, leading collaborative research initiatives. In addition to funding and partnering with Australian research institutes and Foundations, RCD is also active member of the Child’s Brain Tumour Network (CBTN), Paediatric Neuro-Oncology Consortium (PNOC) and the Collaborative Ependymoma Research Network (CERN). We leverage our research investments through partnering with like-minded and passionate organisations to continue to battle paediatric brain cancer.

Our history
The Kids’ Cancer Project is an independent national charity supporting childhood cancer research. Since 1993, the charity has contributed more than $50 million dollars to scientific research projects to help children with many different types of cancer.

Our Goal
Mission: To support bold scientific research that has the greatest chance of clinical success in the improvement of treatments of childhood cancers.

Vision: One hundred per cent survival for children with cancer while eradicating the harmful impacts treatment can bring.

What we stand for
Science: We believe the only way to improve outcomes for kids with cancer is through advances in medical research.

Solutions: Our research priorities reflect our focus on finding better treatments, building research capabilities and supporting survivorship programs.

Survival: Our founder, Col Reynolds OAM, made a promise
to never give up until a cure is found.

Information coming soon.

Information coming soon.

Join the ANZCHOG ASM mailing list

Stay informed with the latest updates
* indicates required